TRIM33 and cancer: Although the plasma VEGF-A levels were not significantly different between the anti-TIF1-γ antibody-positive DM patients without cancer and the healthy controls, our data depicted that VEGF-A levels were significantly upregulated in the Cancer TIF1-γ-DM group than in the Non-cancer TIF1-γ-DM and HC groups (Figures 2 and 3).